An estimated 30 million new cases of Trichomonas vaginalis are recorded annually in sub-Saharan Africa. In Ethiopia, there is no study that systematically compiled the burden of T. vaginalis. Therefore, this study aimed to estimate the pooled prevalence of T. vaginalis in Ethiopia.
Methods
Electronic databases such as PubMed/Medline, EMBASE, Science Direct, Scopus, HINARI, Google Scholar, and Cochrane Library were systematically searched, and studies with high-quality Newcastle Ottawa Scale scores were included. Analyses were performed using STATA version 14 software, and heterogeneity of studies was assessed using the Cochrane’s Q test statistics and I2 test statistics. Sub-group, sensitivity analysis, and publication bias were performed.
Results
Ten eligible studies consisting of 2979 study participants were included. The overall pooled prevalence of T. vaginalis infections in Ethiopia was 9.62%. Sub-group analysis showed that the overall pooled prevalence of T. vaginalis infections in pregnant women and other study groups was 6.68% and 12.86%, respectively. Publication bias was detected by funnel plots and Egger’s tests.
Conclusions
This study showed that the overall pooled prevalence of T. vaginalis infections was relatively high. This study should trigger policy makers, governmental and non-governmental organizations, and healthcare providers to give attention for prevention and control of T. vaginalis infection.
Get full access to this article
View all access options for this article.
References
1.
NourianAShabaniNFazaeliA, et al.Prevalence of trichomonas vaginalis in pregnant women in Zanjan, Northwest of Iran. Jundishapur J Microbiol2013; 6(8): e7258.
2.
ArbabiMFakhriehZDelavariM, et al.Prevalence of trichomonas vaginalis infection in Kashan city, Iran (2012–2013). Iran J Reprod Med2014; 12(7): 507–12.
3.
MatiniMRezaieSMohebaliM, et al.Prevalence of trichomonas vaginalis infection in Hamadan City, Western Iran. Iran J Parasitol2012; 7(2): 67–72.
4.
TineRCSyllaKKaR, et al.A study of Trichomonas vaginalis infection and correlates in women with vaginal discharge referred at Fann Teaching Hospital in Senegal. J Parasitol Res2019; 2019: 2069672.
5.
GlehnMPSáLCSilvaHD, et al.Prevalence of trichomonas vaginalis in women of reproductive age at a family health clinic. J Infect Dev Ctries2017; 11(03): 269–276.
6.
World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. World Health Organization, 2001.
7.
KissingerP. Epidemiology and treatment of trichomoniasis. Curr Infect Dis Rep2015; 17(6): 31.
8.
KissingerP. Epidemiology and treatment of trichomoniasis. Curr Infect Dis Rep2015; 17(6): 31.
9.
De WaaijDJDubbinkJHOuburgS, et al.Prevalence of trichomonas vaginalis infection and protozoan load in South African women: a cross-sectional study. BMJ Open2017; 7(10): e016959.
10.
SchwebkeJRBarrientesFJ. Prevalence of trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother2006; 50(12): 4209–10.
11.
MatiniMRezaieSMohebaliM, et al.Prevalence of trichomonas vaginalis infection in Hamadan City, Western Iran. Iran J Parasitol2012; 7(2): 67–72.
12.
BowdenFJGarnettGP. Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions. Sex Transm Infect2000; 76(4): 248–56.
13.
ArbabiMDelavariMFakhrieh-KashanZ, et al.Review of trichomonas vaginalis in Iran, based on epidemiological situation. J Reprod Infertil2018; 19(2): 82.
14.
MoherDShamseerLClarkeM, et al.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev2015; 4(1): 1–9.
15.
MunnZTufanaruCAromatarisE. JBI’s systematic reviews: data extraction and synthesis. Am J Nurs2014; 114(7): 49–54.
WondmienehAGedefawGAlemnewB, et al.Intestinal parasitic infections and associated factors among people living with HIV/AIDS in Ethiopia: a systematic review and meta-analysis. PLoS One2020; 15(12): e0244887.
18.
BorensteinMHedgesLVHigginsJP, et al.A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods2010; 1(2): 97–111.
19.
MuluWYimerMZenebeY, et al.Common causes of vaginal infections and antibiotic susceptibility of aerobic bacterial isolates in women of reproductive age attending at Felegehiwot referral Hospital, Ethiopia: a cross sectional study. BMC Womens Health2015; 15(1): 42–9.
20.
DestaSFelekeWYusufM, et al.Prevalence of STD and STD related risk factors in sex workers of Addis Ababa. Ethiop J Health Dev1990; 4(2).
21.
EsheteAMekonnenZZeynudinA. Trichomonas vaginalis infection among pregnant women in Jimma university specialized hospital, southwest Ethiopia. Int Sch Res Not2013; 2013.
22.
TamratRKasaTSahilemariamZ, et al.Prevalence and factors associated with sexually transmitted infections among Jimma University students, Southwest Ethiopia. Int J Microbiol2020; 2020.
23.
SchönfeldAFeldtTTufaTB, et al.Prevalence and impact of sexually transmitted infections in pregnant women in central Ethiopia. Int J STD AIDS2018; 29(3): 251–258.
24.
KumsaCHailuA. Prevalence of Trichomonas vaginalis and associated factors of among pregnant women attending antinatal care in governent helath facilities, Ambo town, Western Oromia, Ethiopia. Addis Ababa University, department of Microbiology,Immunology and Parsitologt, 2021.
25.
AdemeMKebedeTFikrieN. Syndromic management approach and wet mount microscopy of trichomonas vaginalis in pregnant women and sexually transmitted infection clinic attendants in Merawi Health Center, Merawi, Amhara regional state, Ethiopia. Int STD Res Rev2013; 1(1): 30–8.
26.
GeremewRAAgizieBMBashawAA, et al.Prevalence of selected sexually transmitted infection (STI) and associated factors among symptomatic patients attending Gondar Town hospitals and health centers. Ethiop J Health Sci2017; 27(6): 589–600.
27.
GeyidATesfayeHSAbrahaA, et al.Isolates of STDs causative agents from sex workers Addis Ababa (a preliminary report). Ethiop J Health Dev1990; 4(2).
28.
ZenebeMHMekonnenZLohaE, et al.Prevalence, risk factors and association with delivery outcome of curable sexually transmitted infections among pregnant women in Southern Ethiopia. PLoS One2021; 16(3): e0248958.
29.
GeremewRAAgizieBMBashawAA, et al.Prevalence of selected sexually transmitted infection (STI) and associated factors among symptomatic patients attending Gondar town hospitals and health centers. Ethiop J Health Sci2017; 27(6): 589–600.
30.
GlehnMPSáLCSilvaHD, et al.Prevalence of trichomonas vaginalis in women of reproductive age at a family health clinic. J Infect Dev Ctries2017; 11(03): 269–276.
31.
HezarjaribiHZFakharMShokriA, et al.Trichomonas vaginalis infection among Iranian general population of women: a systematic review and meta-analysis. Parasitol Res2015; 114(4): 1291–300.
32.
ChemaitellyHWeissHASmolakA, et al.Epidemiology of treponema pallidum, chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis, and herpes simplex virus type 2 among female sex workers in the Middle East and North Africa: systematic review and meta-analytics. J Glob Health2019; 9(2): 020408.
33.
MirzadehMOlfatifarMEslahiAV, et al.Global prevalence of trichomonas vaginalis among female sex workers: a systematic review and meta-analysis. Parasitol Res2021: 120(7): 1–12.
34.
ChicoRMMayaudPAritiC, et al.Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review. JAMA2012; 307(19): 2079–86.
35.
MatiniMRezaieSMohebaliM, et al.Prevalence of trichomonas vaginalis Infection in Hamadan City, Western Iran. Iran J Parasitol2012; 7(2): 67–72.
36.
ArbabiMFakhriehZDelavariM, et al.Prevalence of trichomonas vaginalis infection in Kashan city, Iran (2012–2013). Iran J Reprod Med2014; 12(7): 507–12.
37.
RezaeianMVatanshenasanMRezaeiS, et al.Prevalence of trichomonas vaginalis using parasitological methods in Tehran. Iranian J Parasitol2009; 4(4): 43–47.
38.
SuttonMSternbergMKoumansEH, et al.The prevalence of trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis2007; 45(10): 1319–26.
39.
MeitesELlataEBraxtonJ, et al.Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence. Sex Transm Dis2013; 40(11): 865–9.
40.
Ton NuPANguyenVQCaoNT, et al.Prevalence of trichomonas vaginalis infection in symptomatic and asymptomatic women in Central Vietnam. J Infect Dev Ctries2015; 9(06): 655–60.
41.
AnorluRIFagbenro BeyiokuAFFagoralaT, et al.Prevalence of trichomonas vaginalis in patients with vaginal discharge in Lagos, Nigeria. Niger Postgrad Med J2001; 8(4): 183–6.
42.
De WaaijDJDubbinkJHOuburgS, et al.Prevalence of trichomonas vaginalis infection and protozoan load in South African women: a cross-sectional study. BMJ Open2017; 7(10): e016959.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
